• Users Online: 673
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others


Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan

Chiang Tsung-Ta, Tang Hung-Jen, Chiu Cheng-Hsun, Chen Te-Li, Ho Mao-Wang, Lee Chen-Hsiang, Sheng Wang-Huei, Yang Ya-Sung

Year : 2016| Volume: 36| Issue : 6 | Page no: 229-233

   This article has been cited by
1 Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae
Xi-Wei Ji, Xiao Zhu, Yun Li, Feng Xue, Isabelle Hui San Kuan, Qing-Feng He, Xiang-Rui Meng, Xiao-Qiang Xiang, Yi-Min Cui, Bo Zheng
Frontiers in Pharmacology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
2 Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease
Chien-Ming Chao, Chih-Cheng Lai, Chen-Hsiang Lee, Hung-Jen Tang
Antibiotics. 2022; 11(5): 610
[Pubmed]  [Google Scholar] [DOI]
3 Therapeutic Effectiveness of Cefoperazone for Community-Acquired Pneumonia and Associated Factors in a Tertiary Care Hospital, Vietnam
Cua Ngoc Le, Duong Trung Nguyen, Supreecha Kaewsawat, Charuai Suwangbamrung, Patthanasak Khammaneechan
Journal of Pharmacy and Nutrition Sciences. 2021; 11: 20
[Pubmed]  [Google Scholar] [DOI]
4 Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients
Chun-Ta Huang, Chia-Hung Chen, Wei-Chih Chen, Yao-Tung Wang, Chih-Cheng Lai, Pin-Kuei Fu, Li-Kuo Kuo, Chin-Ming Chen, Wen-Feng Fang, Chih-Yen Tu, Shih-Chi Ku
International Journal of Antimicrobial Agents. 2021; : 106491
[Pubmed]  [Google Scholar] [DOI]
5 Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?
Yee-Huang Ku,Wen-Liang Yu
Infection, Genetics and Evolution. 2021; : 104707
[Pubmed]  [Google Scholar] [DOI]
6 Clinical Efficacy and Safety of Cefoperazone–Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis
Shao-Huan Lan,Chien-Ming Chao,Shen-Peng Chang,Li-Chin Lu,Chih-Cheng Lai
Surgical Infections. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
Ming-Jen Sheu,Chi-Chung Chen,Ying-Chen Lu,Bo-An Su,Chun-Cheng Zhang,Shu-Shen Wang,Yin-Ching Chuang,Hung-Jen Tang,Chih-Cheng Lai
Antibiotics. 2020; 9(2): 77
[Pubmed]  [Google Scholar] [DOI]
8 Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia
Jien-Wei Liu,Yen-Hsu Chen,Wen-Sen Lee,Jung-Chung Lin,Ching-Tai Huang,Hsi-Hsun Lin,Yung-Ching Liu,Yin-Ching Chuang,Hung-Jen Tang,Yao-Shen Chen,Wen-Chien Ko,Min-Chi Lu,Fu-Der Wang
Antimicrobial Agents and Chemotherapy. 2019; 63(8)
[Pubmed]  [Google Scholar] [DOI]
9 The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
Ping-Chin Chang,Chi-Chung Chen,Ying Chen Lu,Chih-Cheng Lai,Hui-Ling Huang,Yin-Ching Chuang,Hung-Jen Tang
Journal of Microbiology, Immunology and Infection. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article